Search research articles
Contact Us
Filters
Showing results (421-430 of 456) with videos related to
Page
of 46
Sort By:
The New England Journal of Medicine
|
December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy
R C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas
W H Wilson, B A Chabner, G Bryant, et al.
The New England Journal of Medicine
|
January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes
G A Curt, D N Carney, K H Cowan, et al.
Cancer Treatment Reports
|
May 1, 1979
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation
S A Rosenburg, B A Chabner, R C Young, et al.
JAMA
|
November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
Thomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials
J A O'Shaughnessy, R E Wittes, G Burke, et al.
The New England Journal of Medicine
|
October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
C J Allegra, B A Chabner, C U Tuazon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
A Roadmap for a New Academic Pathway for Global Radiation Oncology
Adam C Olson, C Norman Coleman, Stephen M Hahn, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome
P Rogers, C J Allegra, R F Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
John W Park, Robert S Kerbel, Gary J Kelloff, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 456) with videos related to
Sort By:
Page
of 46
The New England Journal of Medicine
|
December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy
R C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas
W H Wilson, B A Chabner, G Bryant, et al.
The New England Journal of Medicine
|
January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes
G A Curt, D N Carney, K H Cowan, et al.
Cancer Treatment Reports
|
May 1, 1979
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation
S A Rosenburg, B A Chabner, R C Young, et al.
JAMA
|
November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
Thomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials
J A O'Shaughnessy, R E Wittes, G Burke, et al.
The New England Journal of Medicine
|
October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
C J Allegra, B A Chabner, C U Tuazon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
A Roadmap for a New Academic Pathway for Global Radiation Oncology
Adam C Olson, C Norman Coleman, Stephen M Hahn, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome
P Rogers, C J Allegra, R F Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
John W Park, Robert S Kerbel, Gary J Kelloff, et al.
Page
of 46